Skip to main content
Premium Trial:

Request an Annual Quote

Schuh Surfaces as CEO of Arcturus, a Month after Resigning from Sequenom

NEW YORK, March 7 (GenomeWeb News) - Toni Schuh will serve as the new CEO of Arcturus, the company said today, almost exactly a month after Schuh stepped down as CEO of Sequenom.

 

Arcturus Bioscience, a privately held firm based in Mountain View, Calif., said that Schuh will also be elected to its board of directors.

 

Schuh succeeds former CEO and founder Thomas Baer, who resigned in late 2004 to serve as a consulting professor in the Applied Physics department at StanfordUniversity.

 

Baer continues to serve as a director of Arcturus. Richard Kniss, who has served as a member of the Arcturus Board since January 2002, will be appointed non-executive chairman, the company said.

 

Arcturus sells laser capture microdissection systems for the isolation of single cells, as well as reagents for genomic analysis of microscopic tissue samples.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.